Annual FCF
-$49.31 M
-$4.47 M-9.96%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual free cash flow is -$49.31 million, with the most recent change of -$4.47 million (-9.96%) on December 31, 2023.
- During the last 3 years, IMRX annual FCF has fallen by -$34.64 million (-236.04%).
- IMRX annual FCF is now -1004.89% below its all-time high of -$4.46 million, reached on December 31, 2019.
Performance
IMRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$13.48 M
-$1.92 M-16.60%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly free cash flow is -$13.48 million, with the most recent change of -$1.92 million (-16.60%) on September 30, 2024.
- Over the past year, IMRX quarterly FCF has increased by +$2.05 million (+13.21%).
- IMRX quarterly FCF is now -481.24% below its all-time high of -$2.32 million, reached on March 31, 2020.
Performance
IMRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$52.51 M
-$1.39 M-2.73%
September 30, 2024
Summary
- As of February 8, 2025, IMRX TTM free cash flow is -$52.51 million, with the most recent change of -$1.39 million (-2.73%) on September 30, 2024.
- Over the past year, IMRX TTM FCF has dropped by -$2.12 million (-4.20%).
- IMRX TTM FCF is now -2164.66% below its all-time high of -$2.32 million, reached on March 31, 2020.
Performance
IMRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IMRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.0% | +13.2% | -4.2% |
| 3 y3 years | -236.0% | -14.0% | -17.1% |
| 5 y5 years | -1004.9% | -14.0% | -17.1% |
IMRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -59.5% | at low | -45.7% | +13.2% | -69.9% | at low |
| 5 y | 5-year | -1004.9% | at low | -481.2% | +13.2% | -2164.7% | at low |
| alltime | all time | -1004.9% | at low | -481.2% | +13.2% | -2164.7% | at low |
Immuneering Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.48 M(+16.6%) | -$52.51 M(+2.7%) |
| Jun 2024 | - | -$11.56 M(-25.6%) | -$51.12 M(+1.4%) |
| Mar 2024 | - | -$15.53 M(+30.0%) | -$50.39 M(+2.2%) |
| Dec 2023 | -$49.31 M(+10.0%) | -$11.95 M(-1.1%) | -$49.31 M(+0.3%) |
| Sep 2023 | - | -$12.08 M(+11.5%) | -$49.18 M(+2.2%) |
| Jun 2023 | - | -$10.84 M(-25.0%) | -$48.11 M(+2.6%) |
| Mar 2023 | - | -$14.45 M(+22.2%) | -$46.89 M(+4.6%) |
| Dec 2022 | -$44.84 M | -$11.82 M(+7.3%) | -$44.84 M(+6.1%) |
| Sep 2022 | - | -$11.02 M(+14.6%) | -$42.28 M(+4.9%) |
| Jun 2022 | - | -$9.61 M(-22.4%) | -$40.31 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.40 M(+34.0%) | -$37.15 M(+20.2%) |
| Dec 2021 | -$30.91 M(+110.7%) | -$9.25 M(+2.3%) | -$30.91 M(+13.9%) |
| Sep 2021 | - | -$9.05 M(+40.1%) | -$27.15 M(+25.7%) |
| Jun 2021 | - | -$6.46 M(+4.9%) | -$21.60 M(+16.7%) |
| Mar 2021 | - | -$6.16 M(+12.1%) | -$18.51 M(+26.2%) |
| Dec 2020 | -$14.67 M(+228.8%) | -$5.49 M(+57.3%) | -$14.67 M(+59.8%) |
| Sep 2020 | - | -$3.49 M(+3.5%) | -$9.18 M(+61.3%) |
| Jun 2020 | - | -$3.37 M(+45.5%) | -$5.69 M(+145.5%) |
| Mar 2020 | - | -$2.32 M | -$2.32 M |
| Dec 2019 | -$4.46 M | - | - |
FAQ
- What is Immuneering annual free cash flow?
- What is the all time high annual FCF for Immuneering?
- What is Immuneering annual FCF year-on-year change?
- What is Immuneering quarterly free cash flow?
- What is the all time high quarterly FCF for Immuneering?
- What is Immuneering quarterly FCF year-on-year change?
- What is Immuneering TTM free cash flow?
- What is the all time high TTM FCF for Immuneering?
- What is Immuneering TTM FCF year-on-year change?
What is Immuneering annual free cash flow?
The current annual FCF of IMRX is -$49.31 M
What is the all time high annual FCF for Immuneering?
Immuneering all-time high annual free cash flow is -$4.46 M
What is Immuneering annual FCF year-on-year change?
Over the past year, IMRX annual free cash flow has changed by -$4.47 M (-9.96%)
What is Immuneering quarterly free cash flow?
The current quarterly FCF of IMRX is -$13.48 M
What is the all time high quarterly FCF for Immuneering?
Immuneering all-time high quarterly free cash flow is -$2.32 M
What is Immuneering quarterly FCF year-on-year change?
Over the past year, IMRX quarterly free cash flow has changed by +$2.05 M (+13.21%)
What is Immuneering TTM free cash flow?
The current TTM FCF of IMRX is -$52.51 M
What is the all time high TTM FCF for Immuneering?
Immuneering all-time high TTM free cash flow is -$2.32 M
What is Immuneering TTM FCF year-on-year change?
Over the past year, IMRX TTM free cash flow has changed by -$2.12 M (-4.20%)